BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
5.55
-0.10 (-1.77%)
At close: Nov 13, 2026, 4:00 PM EST
5.37
-0.18 (-3.32%)
After-hours: Nov 13, 2026, 7:53 PM EST
BioAge Labs Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 52.67 | 188.89 | 354.35 | 21.64 | 27.64 |
Short-Term Investments | 230.97 | 92.21 | - | - | - |
Cash & Short-Term Investments | 283.64 | 281.1 | 354.35 | 21.64 | 27.64 |
Cash Growth | -0.75% | -20.67% | 1537.17% | -21.70% | - |
Accounts Receivable | 0.57 | 0.77 | - | - | - |
Other Receivables | 2.3 | 1.2 | 1.2 | - | - |
Receivables | 2.87 | 1.97 | 1.2 | - | - |
Prepaid Expenses | 8.55 | 3.73 | 1.55 | 0.35 | 0.39 |
Restricted Cash | - | - | - | 3.31 | - |
Total Current Assets | 295.05 | 286.79 | 357.1 | 25.31 | 28.03 |
Property, Plant & Equipment | 3.61 | 3.75 | 0.79 | 0.52 | 0.37 |
Long-Term Investments | 68.68 | 4.13 | 0.1 | 0.1 | - |
Other Long-Term Assets | 0.31 | 0.22 | 0.24 | - | 0.03 |
Total Assets | 367.65 | 294.89 | 358.23 | 25.92 | 28.43 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 1.89 | 2.67 | 2 | 1.87 | 2.26 |
Accrued Expenses | 11.38 | 7.96 | 11.33 | 6.55 | 3.36 |
Short-Term Debt | - | - | - | 38.86 | - |
Current Portion of Long-Term Debt | - | 2.65 | 6 | 6 | 0.17 |
Current Portion of Leases | 0.72 | 0.58 | 0.2 | 0.19 | 0.05 |
Current Unearned Revenue | 4.63 | 5.75 | 7.83 | 3.31 | - |
Other Current Liabilities | 0.4 | 0.53 | 0.42 | 1.39 | 0.02 |
Total Current Liabilities | 19.03 | 20.14 | 27.78 | 58.17 | 5.86 |
Long-Term Debt | - | - | 2.5 | 8.2 | 2.25 |
Long-Term Leases | 2.01 | 2.33 | - | - | - |
Long-Term Unearned Revenue | - | - | 4.67 | - | - |
Other Long-Term Liabilities | 0.16 | 0.37 | 0.16 | 0.23 | 0.15 |
Total Liabilities | 21.2 | 22.84 | 35.11 | 66.6 | 8.27 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Additional Paid-In Capital | 762.88 | 605.19 | 575.69 | 8.14 | 5.12 |
Retained Earnings | -415.27 | -333.42 | -252.81 | -181.7 | -117.85 |
Comprehensive Income & Other | -1.17 | 0.28 | 0.25 | 0.16 | 0.17 |
Total Common Equity | 346.45 | 272.05 | 323.13 | -173.4 | -112.56 |
Shareholders' Equity | 346.45 | 272.05 | 323.13 | -40.67 | 20.16 |
Total Liabilities & Equity | 367.65 | 294.89 | 358.23 | 25.92 | 28.43 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 2.73 | 5.56 | 8.7 | 53.25 | 2.47 |
Net Cash (Debt) | 349.59 | 279.57 | 345.65 | -31.61 | 25.18 |
Net Cash Growth | 21.08% | -19.12% | - | - | - |
Net Cash Per Share | 8.25 | 7.78 | 32.22 | -18.90 | 15.06 |
Filing Date Shares Outstanding | 45.96 | 44.38 | 35.85 | 1.67 | 1.67 |
Total Common Shares Outstanding | 45.95 | 37.39 | 35.85 | 1.67 | 1.67 |
Working Capital | 276.03 | 266.66 | 329.33 | -32.86 | 22.17 |
Book Value Per Share | 7.54 | 7.28 | 9.01 | -103.62 | -67.33 |
Tangible Book Value | 346.45 | 272.05 | 323.13 | -173.4 | -112.56 |
Tangible Book Value Per Share | 7.54 | 7.28 | 9.01 | -103.62 | -67.33 |
Machinery | 1.66 | 1.26 | 0.79 | 0.74 | 0.58 |
Construction In Progress | - | 0.02 | 0.18 | - | - |
Leasehold Improvements | 0.16 | 0.16 | - | - | - |